Ostatné · TMO
Thermo Fisher Scientific Inc.
Fundamenty firmy Healthcare · Diagnostics & Research · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 26 hodnotení
nákup
- Najnižší cieľ
- 520,00
- Priemerný cieľ
- 652,85
- Najvyšší cieľ
- 780,00
- Potenciál
- −1,8 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | 6,41 | 6,33–6,56 | 5,79 | +10,7 % |
| budúci štvrťrok | 7,26 | 7,12–7,40 | 6,57 | +10,5 % |
| tento rok | 25,13 | 24,98–25,40 | 22,87 | +9,9 % |
| budúci rok | 27,55 | 26,49–29,07 | 25,13 | +9,6 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 11,9 mld. | 11,1 mld. | +7,4 % |
| budúci štvrťrok | 12,9 mld. | 12,2 mld. | +5,7 % |
| tento rok | 47,9 mld. | 44,6 mld. | +7,4 % |
| budúci rok | 50,3 mld. | 47,9 mld. | +5,1 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Pettiti GianlucaPresident | uplatnenie opcií | 1,2 mil. | 31.08. |
| Pettiti GianlucaPresident | predaj | 2,5 mil. | 31.08. |
| Casper Marc NChief Executive Officer | uplatnenie opcií | 85 148 | 24.08. |
| Casper Marc NChief Executive Officer | predaj | 172 439 | 24.08. |
| Casper Marc NChief Executive Officer | uplatnenie opcií | 6,2 mil. | 21.08. |
| Casper Marc NChief Executive Officer | predaj | 12,6 mil. | 21.08. |
| Britt Lisa POfficer | uplatnenie opcií | 4,8 mil. | 19.08. |
| Britt Lisa POfficer | predaj | 7,0 mil. | 19.08. |
| Shafer Michael DOfficer | uplatnenie opcií | 9,4 mil. | 11.08. |
| Shafer Michael DOfficer | predaj | 15,3 mil. | 11.08. |
| Holmes Joseph R.Officer | uplatnenie opcií | 130 045 | 07.08. |
| Casper Marc NChief Executive Officer | uplatnenie opcií | 85 148 | 07.08. |
Kto vlastní akcie
Blackrock Inc.8,36 %
Vanguard Capital Management LLC6,57 %
State Street Corporation4,55 %
FMR, LLC3,81 %
Morgan Stanley2,91 %
JPMORGAN CHASE & CO2,30 %
Geode Capital Management, LLC2,27 %
Franklin Resources, Inc.1,97 %
O firme (popis z Yahoo Finance, anglicky)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
📅 Výsledky hospodárenia: Streda 21. 10. · odhad EPS 6,41
Technické signály
- Rastový trend – Kurz nad SMA50 aj SMA200, SMA50 nad SMA200
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou TMO.